Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.

Source:http://linkedlifedata.com/resource/pubmed/id/18922909

Cancer Res. 2008 Oct 15 68 20 8369-76

Download in:

View as

General Info

PMID
18922909